Skip to main content
Equibles

MORGAN STANLEY

Position in VRCA — Verrica Pharmaceuticals Inc.

CIK 895421 NEW YORK, NY
Back to VRCA Full portfolio

Position in VRCA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$19,590
-$98,831 QoQ
Shares Held
3,201
-85.7% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 43 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in VRCA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. VRCA ranks #403 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in VRCA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,590 3,201
2026-03-31 $118,421 22,386
2025-12-31 $182,894 22,009
2025-09-30 $93,475 21,688
2025-06-30 $13,920 26,266
2025-03-31 $30,683 69,423
2024-12-31 $253,249 361,787
2024-09-30 $263,580 181,781
2024-06-30 $619,203 84,939
2024-03-31 $794,556 134,216
2023-12-31 $814,750 111,305
2023-09-30 $462,239 118,981
2023-06-30 $275,082 47,675
2023-03-31 $1,068,553 164,393
2022-12-31 $36,456 13,257
2022-09-30 $123,697 42,363
2022-06-30 $180,649 94,089
2022-03-31 $6,339,683 781,712
2021-12-31 $8,344,647 910,988
2021-09-30 $557,249 44,580
2021-06-30 $1,379,332 122,065
2021-03-31 $70,038 4,623
2020-12-31 $157,294 13,666
2020-09-30 $43,397 5,607
2020-06-30 $92,714 8,421
2020-03-31 $60,551 5,540